Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin T. Conroy Insider Profile
11 Followers
Kevin T. Conroy, President & CEO, Director at Exact Sciences, holds 1.39M shares in Exact Sciences (Ticker: EXAS), holds 22.97K shares in Adaptive Biotechnologies (Ticker: ADPT), holds 0.00 shares in Epizyme (Ticker: EPZM).
Kevin T. Conroy Exact Sciences (EXAS)President & CEO, Director
Exact Sciences (EXAS)
President & CEO, Director
Ranked #23,950 out of 98,564 Corporate Insiders
Profitable Transactions
5 out of 10 Profitable Transactions
Average Return
+5.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin T. Conroy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin T. Conroy
Kevin T. Conroy's Trading History
Exact Sciences
Mar 04, 2024
President & CEO, Director
Uninformative Sell
490.64K
$88.47M
Epizyme
Aug 16, 2022
―
Uninformative Sell
―
$0.00
Adaptive Biotechnologies
Mar 08, 2023
Director
Uninformative Buy
―
$59.26K
ARYA Sciences Acquisition
―
―
―
―
SomaLogic
Sep 03, 2021
―
Uninformative Buy
―
$52.50K
Align Tech
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Kevin T. Conroy's performance on stock
You May Also Like
Kevin T. Conroy insider profile FAQ
What is the percentage of profitable transactions made by Kevin T. Conroy?
The percentage of profitable transactions made by Kevin T. Conroy is 50%.
What is the average return per transaction made by Kevin T. Conroy?
The average return per transaction made by Kevin T. Conroy is 5.20%.
What stocks does Kevin T. Conroy hold?
Kevin T. Conroy holds: EXAS, EPZM, ADPT, ~ARYA, SLGC, ALGN stocks.
What was Kevin T. Conroy’s latest transaction?
Kevin T. Conroy latest transaction was an Uninformative Sell of $490.64K.
What was Kevin T. Conroy's most profitable transaction?
Kevin T. Conroy’s most profitable transaction was an Informative Buy of EXAS stock on January 13, 2016. The return on the trade was 184.10%.
What is Kevin T. Conroy's role in Exact Sciences?
Kevin T. Conroy's role in Exact Sciences is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.